Zscaler Unveils New Innovations to Secure Enterprise AI Adoption
SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ:…
Zscaler 2026 AI Threat Report: 91% Year-over-Year Surge in AI Activity Creates Growing Oversight Gap for Global Enterprises
News Highlights AI adoption is accelerating faster than enterprise oversight. Despite 200%…
Real-World Commercial Experience with Ryoncil Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
January 26, 2026 18:45 ET | Source: Mesoblast Limited NEW YORK, Jan.…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
January 26, 2026 17:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
HNL Lab Medicine Employees Select Local Charities for Annual Donation
ALLENTOWN, Pa., Jan. 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine continues…
Virtune AB (Publ) is launching Virtune BNB ETP on Nasdaq Stockholm
January 26, 2026 03:50 ET | Source: Virtune AB (Publ) Stockholm, January…
5/2026Trifork Group: Weekly report on share buyback
Schindellegi, Switzerland – 26 January 2026 Trifork Group AGCompany announcement no. 5/2026…
Banqup secures additional shareholder funding, recalibrates covenants with Francisco Partners and signs an agreement for the sale of Baltic operations
Press Release - Inside Information La Hulpe, Belgium –26 January 2026, 7:00…
Lake Erie College of Osteopathic Medicine Designs Medical Education Around Multiple Learning Pathways to Support Different Learning Styles
Erie, PA, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Medical education is often…
FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment…
